Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/31877
Title: | Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial | Authors: | Behr, Jürgen Demedts, Maurits Buhl, Roland Costabel, Ulrich Dekhuijzen, Richard P.N. Jansen, Henk M. MacNee, William THOMEER, Michiel Wallaert, Benoit Laurent, François Nicholson, Andrew G. Verbeken, Eric K. Verschakelen, Johny Flower, C.D.R. Petruzzelli, Stefano De Vuyst, Paul van den Bosch, J.M.M. Rodriguez-Becerra, Eulogio Lankhorst, Ida Sardina, Marco Boissard, Gabrielle |
Corporate Authors: | Ifigenia Study Group | Issue Date: | 2009 | Source: | RESPIRATORY RESEARCH, 10 (1) (Art N° 101) | Abstract: | Background: The randomized placebo-controlled IFIGENIA-trial demonstrated that therapy with high-dose N-acetylcysteine (NAC) given for one year, added to prednisone and azathioprine, significantly ameliorates (i.e. slows down) disease progression in terms of vital capacity (VC) (+9%) and diffusing capacity (DLco) (+24%) in idiopathic pulmonary fibrosis (IPF). To better understand the clinical implications of these findings we performed additional, explorative analyses of the IFGENIA data set. | Document URI: | http://hdl.handle.net/1942/31877 | e-ISSN: | 1465-993X | DOI: | 10.1186/1465-9921-10-101 | ISI #: | WOS:000271637700002 | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1465-9921-10-101.pdf | Published version | 1.05 MB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
55
checked on Sep 13, 2024
Page view(s)
18
checked on Sep 7, 2022
Download(s)
12
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.